Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
55.3M
-
Shares change
-
+10.8M
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$249M
-
Put/Call ratio
-
2.22
-
Number of buys
-
66
-
Number of sells
-
-35
-
Price
-
$23.11
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2020
126 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q1 2020.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.3M shares
.
Largest 10 shareholders include FMR LLC (9.37M shares), BAUPOST GROUP LLC/MA (9.31M shares), BlackRock Inc. (8.78M shares), Link Fund Solutions Ltd (4.84M shares), VANGUARD GROUP INC (4.43M shares), WELLINGTON MANAGEMENT GROUP LLP (4.17M shares), NORGES BANK (1.06M shares), STATE STREET CORP (1.06M shares), Chescapmanager LLC (1M shares), and PERCEPTIVE ADVISORS LLC (1M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.